Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support
NIDA aims to create a Center to train and support researchers in developing new treatments for substance use disorders, offering education, networking, and resources for early-stage product development.
Funder: National Institutes of Health
Due Dates: September 30, 2026
Funding Amounts: Estimated total program funding: $3,000,000 | 1 expected award
Summary: Supports establishing a Center to train researchers in SUD pharmacotherapeutics development and provide technical and financial support for advancing new concepts.
Description
This funding opportunity aims to establish a Center dedicated to advancing the development of pharmacotherapeutics for substance use disorders (SUD). The Center will focus on training researchers in the formal process of product development for new SUD treatments and will provide both technical and financial support to move promising concepts through initial preclinical experiments. The overarching goal is to accelerate the development and translation of innovative SUD therapies by building workforce capacity and supporting early-stage research.
